SBTX · Categories · Form 4

SBTX - SEC Form 4 insider transactions

Silverback Therapeutics Inc. (SBTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SBTX

• 880d
  Lowenthal Richard E gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 20% to 4,126,822 units (SEC Form 4)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  Tanimoto Sarina gifted 2,100,000 shares and received a gift of 2,100,000 shares, decreasing direct ownership by 24% to 3,276,854 units (SEC Form 4)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  SEC Form 4 filed by Dorsey Brian

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  SEC Form 4 filed by Chakma Justin

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 880d
  SEC Form 4 filed by Fitzpatrick Alexander A

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1001d
  SEC Form 4: Shawver Laura exercised 100,000 shares at a strike of $1.27 and sold $770,520 worth of shares (100,000 units at $7.71)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1006d
  SEC Form 4: Ra Capital Management, L.P. bought $23,250,000 worth of shares (3,750,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1006d
  SEC Form 4: Orbimed Advisors Llc bought $3,100,000 worth of shares (500,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1006d
  SEC Form 4: Thompson Peter A. bought $3,100,000 worth of shares (500,000 units at $6.20)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1030d
  SEC Form 4: Shawver Laura exercised 45,004 shares at a strike of $1.27 and sold $316,489 worth of shares (45,004 units at $7.03)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1034d
  SEC Form 4: Shawver Laura exercised 54,996 shares at a strike of $1.27 and sold $391,841 worth of shares (54,996 units at $7.12)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1061d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1062d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Dadoo Rajeev

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Shah Pratik

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Kelly Michael

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Thompson Peter A.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Schneider Phillip M

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Saunders Brent L

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1070d
  SEC Form 4 filed by Islam Saqib

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1096d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1119d
  SEC Form 4 filed by Shawver Laura

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Dorsey Brian

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Chakma Justin

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Fitzpatrick Alexander A

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Lowenthal Richard E

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1244d
  SEC Form 4 filed by Tanimoto Sarina

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1279d
  SEC Form 4: Scott Kathleen D. bought $51,506 worth of shares (8,250 units at $6.24)

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Ra Capital Management, L.P. was granted 3,009,678 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4 filed by Schneider Phillip M

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4 filed by Karas Eric

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Shah Pratik was granted 10,156,204 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Chakma Justin was granted 236,380 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4 filed by Saunders Brent L

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Tanimoto Sarina was granted 12,199,408 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Lowenthal Richard E was granted 13,049,376 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Dadoo Rajeev was granted 3,009,677 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4 filed by Scott Kathleen D.

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1300d
  SEC Form 4: Kelly Michael was granted 83,225 shares

  4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Thompson Peter A.

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Root Jonathan D

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Powell Andrew Kenneth William

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Koehler Maria

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Islam Saqib

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Hershberg Robert

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1450d
  SEC Form 4 filed by Capps Vickie L

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1490d
  SEC Form 4: Shawver Laura was granted 68,107 shares, increasing direct ownership by 63% to 175,502 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1490d
  SEC Form 4: Piazza Jonathan was granted 43,691 shares, increasing direct ownership by 171% to 69,225 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1490d
  SEC Form 4: Odegard Valerie was granted 45,233 shares, increasing direct ownership by 276% to 61,639 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1490d
  SEC Form 4: Hunder Naomi was granted 43,177 shares, increasing direct ownership by 384% to 54,427 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1490d
  SEC Form 4: Hawkinson Russ was granted 28,335 shares, increasing direct ownership by 318% to 37,251 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1537d
  SEC Form 4: Root Jonathan D bought $36,048 worth of shares (2,364 units at $15.25)

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1559d
  SEC Form 4: Hawkinson Russ bought $4,200 worth of shares (200 units at $21.00) (Amendment)

  4/A - Silverback Therapeutics, Inc. (0001671858) (Issuer)
• 1581d
  SEC Form 4: Hawkinson Russ was granted 7,500 shares, increasing direct ownership by 516% to 8,954 units

  4 - Silverback Therapeutics, Inc. (0001671858) (Issuer)

Other SBTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends